Recalcitrant viral warts treated by diphencyprone immunotherapy

British Journal of Dermatology

Volumn 141, Issue 2, 1999, Pages 292-296

  Buckley, D A ^a   Keane, F M ^a   Munn, S E ^a   Fuller, L C ^a   Higgins, E M ^a   Du Vivier, A W P ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Contact sensitivity; Diphencyprone; Immunotherapy; Viral warts

Indexed keywords

DIPHENCYPRONE;

ARTICLE; BULLOUS SKIN DISEASE; CLINICAL TRIAL; CONTACT SENSITIZATION; DRUG EFFICACY; ECZEMA; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VERRUCA PLANTARIS; WART VIRUS;

ADOLESCENT; ADULT; AGED; CHILD; CHRONIC DISEASE; CYCLOPROPANES; FEMALE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME; WARTS;

EID: 0032808816     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02978.x     Document Type: Article

References (29)

1. Munn SE, Higgins E, Marshall M, Clement M. A new method of intralesional blcomyrin therapy in the treatment of recalcitrant warts. Br J Dermatol 1996; 135: 969-71.
2. Kubeyinje EP. Evaluation of the effIcacy and safety of 0.05% tretinoin cream in the treatment of plane warts in Arab children. J Dermatol Treat 1996; 7; 21-2.
3. Webster GF, Satur N, Goldman MP et al. Treatment of recalcitrant warts using the pulsed dye laser. Cutis 1995; 56: 230-2.
4. Gooptu C, Higgins CR, James MR Successful treatment of multiple viral warts with cimetidine. Br J Dermatol 1997; 137 (Suppl. 50): 51; (Abstr.).
5. Lewis HM. Topical immunotherapy of refractory warts. Cutis 1973; 12: 863-7.
6. Claudy AL, Roche H, Traitement des verrues multiples et récidivantes par induction d'une hypersensibililté retardée. Etude critique de l'utilisation du dibutylester de l'acide squarique. Ann Dermatol Venereol 1981; 108; 765-7.
7. Wiesner-Menzel L, Happle R. Rückbildung von Plantarwarzen nach Behandlung mit Diphencyprone. Z. Hautkr 1984; 59: 1080-3.
8. Lane PR, Hogan DJ. Diphencyprone. (Letter.) J Am Acad Dermatol 1988; 19: 364-5.
9. Naylor MF, Neldner KH, Yarbrough GK et al. Contact immunotherapy of resistant warts. J Am Acad Dermatol 1988; 19; 679-83.
10. Orecchia G, Douville H, Santagostino I, Rabbiosi G. Treatment of multiple relapsing warts with diphenciprone. Dermatologica 1988; 177: 225-31.
11. Rampen FHJ, Steijlen I'M, Diphencyprone in the management of refractory palmoplantar and periungual warts: an open study. Dermatol 1996: 193: 236-8.
12. van der Steen P., van de Kerkhof P. Der Kinderen D et al. Clinical and immunohistochemical responses of plantar warts to topical immunotherapy with diphenylcyclopropenone. J Dermatol 1991; 18: 330-3.
13. Happle R, Hausen BM, Wiesner-Menzel L. Diphencyprone in the treatment of alopecia areata. Acta Derm Venercol (Stockh) 1983; 63: 49-52.
14. Harland CC, Saihan EM. Regression of cutaneous metastatic malignant melanoma with topical diphencyprone and oral cimetidine. (Letter.) Lancet 1989; ii: 445.
15. Bekhor PS, Entwisle BR, McKenzie IFC. Topical DNCB therapy for resistant warts. Australas J Dermatol 1978: 19: 28-30.
16. Claudy AL, Roche H, Gogue Y. Traitement des verrues multiples et rėcidivantes par induction d'une hypersensibilité retardée. Ann Dermatol Venereol 1980; 107; 551-3.
17. Dunagin WG. Millikun LE, Dinitrochlorobenzene immunotherapy for verrucae resistant to standard treatment modalities. J Am Acad Dermatol 1982; 6: 40-5.
18. Eriksen K. Treatment of the common wart by induced allergic inflammation. Dermatologica 1980; 160; 161-6.
19. Goihman-Jahr M, Fernundez J, Convit J. Immunoterapia de las verrugas vulgares diseminadas con dinitrochlorobenceno, Med Cutan Iber Latin Am 1976; 2: 187-94.
20. Nater JP, Burr AJM, Bleumink K. De behandleling van verrucae vultgares met 2,4-dinitrochloorbenzeen (DNCB). Ned Tijdschr Geneeskd 1979; 123: 603-6.
21. Berth-Jones J, McBurney A, Hutchinson PE. Diphencyprone is not detectable in scrum or urine after topical application. Acta Derm Venereal (Stockh) 1994; 74; 312-13.
22. Wilkerson MG, Connor TH, Henkin J et al. Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay. J Am Acad Dermatol 1987; 17: 606-11.
23. Massing AM, Epstein WL. Natural history of warts. A two-year study. Arch Dermatol 1963; 87: 306-10.
24. Goihman-Yahr M, Fernandez J. Boatswain A, Convit J. Unilateral dinitrochlorohenzene immunopathy of recalcitrant warts. Lancet 1978; i: 447-8.
25. Puig L, Alegre M, Erythema multiforme-like reaction following diphencyprone treatment of plane warts. Int J Dermatol 1994; 33: 20-3.
26. Monk B. Induction of hair growth in alopecia totalis with diphencyprone sensitistition. Clin Exp Dermatol 1989; 14: 154-7.
27. Handerson CA, Ilchyshyn A. Vitilino complicating diphencyprone sensitization therapy for alopecia universalis. Br J Dermatol 1995; 133; 496-7.
28. van der Steen P, Happle R. 'Dyschromia in confetti' as a side-effect of topical immunotherapy with diphenylcyclopropenone. Arch Dermatol 1992; 128: 518-20.
29. Shah M, Lewis FM, Messenger AG, Hazards in the use of diphencyprone. (Letter.) Br J Dermatol 1996; 134; 11-53.